eISSN: 2084-9869
ISSN: 1233-9687
Polish Journal of Pathology
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
3/2021
vol. 72
 
Share:
Send email
Share:
abstract:
Original paper

Evaluation of EZH2 and ERRα in colorectal carcinoma: an immunohistochemical study

Hoda H. Abou Gabal
1
,
Naglaa S. Ahmed
1
,
Ghada R. Meckawy
2
,
Radwa A. E. A. Yassin
2
,
Sarah A. Hakim
1

  1. Department of Pathology, Faculty of Medicine, Ain Shams University, Egypt
  2. Department of Clinical Oncology, Faculty of Medicine, Ain Shams University, Egypt
Pol J Pathol 2021; 72 (1): 200-210
DOI: https://doi.org/10.5114/pjp.2021.111770
Online publish date: 2022/01/20
View full text Get citation
 
PlumX metrics:
The combined immunohistochemical evaluation of EZH2 (enhancer of zeste homolog 2) and ERRα (estrogen-related receptor α), in relation to clinicopathological prognostic factors and patients’ outcome, has not been performed yet in colorectal carcinoma (CRC). In order to achieve this aim, 120 samples were extracted;

60 cases of CRC; and 60 samples from normal colonic tissue.

Our study showed that 63.3% and 38.3% of CRC cases reveal high EZH2 and high ERRα nuclear expression, respectively. 6.6% and 8.3% of normal colonic mucosa samples express low EZH2 and low ERRα nuclear expression, respectively. High EZH2 and high ERRα expression correlate with late tumor stages (p = 0.001 each), high grade (p = 0.001, p = 0.009 respectively), positive lymph node involvement (p = 0.001, p = 0.002 respectively) and larger tumor size (p = 0.001 each). There is a moderate highly statistically significant agreement (κ = 0.467, p = 0.001) between EZH2 and ERRα immunohistochemical expression. By Kaplan Meier analysis, high EZH2 and high ERRα show statistically significant shorter overall survival, and progression free survival than cases with low EZH2 and low ERRα immunohistochemical expression, respectively. Thus, EZH2 and ERRα might serve as potential promising prognostic markers in CRC.
keywords:

EZH2, ERRα, colorectal carcinoma, normal colonic tissue, immunohistochemistry, prognostic
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.